Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax

The PfCLAG9 has been extensively studied because their immunogenicity. Thereby, the gene product is important for therapeutics interventions and a potential vaccine candidate. Antibodies against synthetic peptides corresponding to selected sequences of the Plasmodium falciparum antigen PfCLAG9 were...

Full description

Bibliographic Details
Main Authors: Joana D'Arc Neves Costa, Fernando Berton Zanchi, Francisco Lurdevanhe da Silva Rodrigues, Eduardo Rezende Honda, Tony Hiroschi Katsuragawa, Dhélio Batista Pereira, Roger Lafontaine Mesquita Taborda, Mauro Shugiro Tada, Ricardo de Godoi Mattos Ferreira, Luiz Hildebrando Pereira-da-Silva
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2013-02-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762013000100016
_version_ 1797758460513746944
author Joana D'Arc Neves Costa
Fernando Berton Zanchi
Francisco Lurdevanhe da Silva Rodrigues
Eduardo Rezende Honda
Tony Hiroschi Katsuragawa
Dhélio Batista Pereira
Roger Lafontaine Mesquita Taborda
Mauro Shugiro Tada
Ricardo de Godoi Mattos Ferreira
Luiz Hildebrando Pereira-da-Silva
author_facet Joana D'Arc Neves Costa
Fernando Berton Zanchi
Francisco Lurdevanhe da Silva Rodrigues
Eduardo Rezende Honda
Tony Hiroschi Katsuragawa
Dhélio Batista Pereira
Roger Lafontaine Mesquita Taborda
Mauro Shugiro Tada
Ricardo de Godoi Mattos Ferreira
Luiz Hildebrando Pereira-da-Silva
author_sort Joana D'Arc Neves Costa
collection DOAJ
description The PfCLAG9 has been extensively studied because their immunogenicity. Thereby, the gene product is important for therapeutics interventions and a potential vaccine candidate. Antibodies against synthetic peptides corresponding to selected sequences of the Plasmodium falciparum antigen PfCLAG9 were found in sera of falciparum malaria patients from Rondônia, in the Brazilian Amazon. Much higher antibody titres were found in semi-immune and immune asymptomatic parasite carriers than in subjects suffering clinical infections, corroborating original findings in Papua Guinea. However, sera of Plasmodium vivax patients from the same Amazon area, in particular from asymptomatic vivax parasite carriers, reacted strongly with the same peptides. Bioinformatic analyses revealed regions of similarity between P. falciparum Pfclag9 and the P. vivax ortholog Pvclag7. Indirect fluorescent microscopy analysis showed that antibodies against PfCLAG9 peptides elicited in BALB/c mice react with human red blood cells (RBCs) infected with both P. falciparum and P. vivax parasites. The patterns of reactivity on the surface of the parasitised RBCs are very similar. The present observations support previous findings that PfCLAG9 may be a target of protective immune responses and raises the possibility that the cross reactive antibodies to PvCLAG7 in mixed infections play a role in regulate the fate of Plasmodium mixed infections.
first_indexed 2024-03-12T18:30:18Z
format Article
id doaj.art-c888fb38d5a848b687e717e7aa783798
institution Directory Open Access Journal
issn 0074-0276
1678-8060
language English
last_indexed 2024-03-12T18:30:18Z
publishDate 2013-02-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-c888fb38d5a848b687e717e7aa7837982023-08-02T08:19:27ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz0074-02761678-80602013-02-01108198105Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivaxJoana D'Arc Neves CostaFernando Berton ZanchiFrancisco Lurdevanhe da Silva RodriguesEduardo Rezende HondaTony Hiroschi KatsuragawaDhélio Batista PereiraRoger Lafontaine Mesquita TabordaMauro Shugiro TadaRicardo de Godoi Mattos FerreiraLuiz Hildebrando Pereira-da-SilvaThe PfCLAG9 has been extensively studied because their immunogenicity. Thereby, the gene product is important for therapeutics interventions and a potential vaccine candidate. Antibodies against synthetic peptides corresponding to selected sequences of the Plasmodium falciparum antigen PfCLAG9 were found in sera of falciparum malaria patients from Rondônia, in the Brazilian Amazon. Much higher antibody titres were found in semi-immune and immune asymptomatic parasite carriers than in subjects suffering clinical infections, corroborating original findings in Papua Guinea. However, sera of Plasmodium vivax patients from the same Amazon area, in particular from asymptomatic vivax parasite carriers, reacted strongly with the same peptides. Bioinformatic analyses revealed regions of similarity between P. falciparum Pfclag9 and the P. vivax ortholog Pvclag7. Indirect fluorescent microscopy analysis showed that antibodies against PfCLAG9 peptides elicited in BALB/c mice react with human red blood cells (RBCs) infected with both P. falciparum and P. vivax parasites. The patterns of reactivity on the surface of the parasitised RBCs are very similar. The present observations support previous findings that PfCLAG9 may be a target of protective immune responses and raises the possibility that the cross reactive antibodies to PvCLAG7 in mixed infections play a role in regulate the fate of Plasmodium mixed infections.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762013000100016malariaimmunityAmazoncross-reaction
spellingShingle Joana D'Arc Neves Costa
Fernando Berton Zanchi
Francisco Lurdevanhe da Silva Rodrigues
Eduardo Rezende Honda
Tony Hiroschi Katsuragawa
Dhélio Batista Pereira
Roger Lafontaine Mesquita Taborda
Mauro Shugiro Tada
Ricardo de Godoi Mattos Ferreira
Luiz Hildebrando Pereira-da-Silva
Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax
Memorias do Instituto Oswaldo Cruz
malaria
immunity
Amazon
cross-reaction
title Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax
title_full Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax
title_fullStr Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax
title_full_unstemmed Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax
title_short Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax
title_sort cross reactive anti pfclag9 antibodies in the sera of asymptomatic parasite carriers of plasmodium vivax
topic malaria
immunity
Amazon
cross-reaction
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762013000100016
work_keys_str_mv AT joanadarcnevescosta crossreactiveantipfclag9antibodiesintheseraofasymptomaticparasitecarriersofplasmodiumvivax
AT fernandobertonzanchi crossreactiveantipfclag9antibodiesintheseraofasymptomaticparasitecarriersofplasmodiumvivax
AT franciscolurdevanhedasilvarodrigues crossreactiveantipfclag9antibodiesintheseraofasymptomaticparasitecarriersofplasmodiumvivax
AT eduardorezendehonda crossreactiveantipfclag9antibodiesintheseraofasymptomaticparasitecarriersofplasmodiumvivax
AT tonyhiroschikatsuragawa crossreactiveantipfclag9antibodiesintheseraofasymptomaticparasitecarriersofplasmodiumvivax
AT dheliobatistapereira crossreactiveantipfclag9antibodiesintheseraofasymptomaticparasitecarriersofplasmodiumvivax
AT rogerlafontainemesquitataborda crossreactiveantipfclag9antibodiesintheseraofasymptomaticparasitecarriersofplasmodiumvivax
AT mauroshugirotada crossreactiveantipfclag9antibodiesintheseraofasymptomaticparasitecarriersofplasmodiumvivax
AT ricardodegodoimattosferreira crossreactiveantipfclag9antibodiesintheseraofasymptomaticparasitecarriersofplasmodiumvivax
AT luizhildebrandopereiradasilva crossreactiveantipfclag9antibodiesintheseraofasymptomaticparasitecarriersofplasmodiumvivax